<DOC>
	<DOCNO>NCT00743899</DOCNO>
	<brief_summary>The aim study compare conservative versus aggressive strategy patient intermediate lesion angiography guidance alone .</brief_summary>
	<brief_title>Conservative Versus Aggressive Revascularization Patients With Intermediate Lesions Undergoing Percutaneous Coronary Intervention With Angiography Guidance Alone</brief_title>
	<detailed_description>To investigate whether conservative revascularization use criterion 70 % diameter stenosis would non-inferior aggressive revascularization use criterion 50 % diameter stenosis coronary intermediate lesion , conduct Conservative Revascularization versus Aggressive Revascularization Coronary Stenting Everolimus-Eluting Stents ( SMART-CASE ) trial .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Intermediate coronary lesion ( ) ( diameter stenosis 50 % 70 % quantitative coronary analysis ) Target lesion ( ) must locate native coronary artery diameter ≥2.25 mm ≤4.25 mm cardiogenic shock myocardial infarction ( MI ) within 48 hour leave main lesion drugeluting stent implantation target vessel prior enrollment ≥2 chronic total occlusion major coronary territory history bleed diathesis know coagulopathy gastrointestinal genitourinary bleeding within 3 month major surgery within 2 month platelet count &lt; 100,000 cells/mm3 plan elective surgical procedure would necessitate interruption thienopyridine first 6 month enrollment noncardiac comorbid condition life expectancy &lt; 1 year may result protocol noncompliance ( per site investigator 's medical judgment ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Angioplasty , Transluminal , Percutaneous Coronary</keyword>
	<keyword>Everolimus-eluting stent</keyword>
</DOC>